Literature DB >> 17122453

The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands.

A E de Jong1, H F A Vasen.   

Abstract

BACKGROUND: Subjects with a positive family history of colorectal cancer (CRC) have an increased risk of developing CRC themselves. This risk depends on the number of affected relatives and the age at diagnosis. AIM: The aim of this study was to assess the prevalence of a positive family history of CRC, within a random cohort among the dutch population.
METHODS: A total of 5072 subjects aged between 45 and 70 years were invited to fill in an anonymous questionnaire about the occurrence of CRC in their first-degree relatives (FDR).
RESULTS: The questionnaire was returned by 3973 subjects (78.3%). Thirty responders (0.8%) had CRC themselves. Of all unaffected responders, 441 (11.2%) subjects reported a positive family history of CRC. Ninety (2.3%) responders reported having an FDR with CRC diagnosed before the age of 50, or reported two or more FDRs with CRC.
CONCLUSION: The prevalence of a positive family history of CRC is substantial. Identification of this high-risk group by obtaining a thorough family history is the first step in targeting preventive measures.

Entities:  

Mesh:

Year:  2006        PMID: 17122453

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  14 in total

1.  Screening colonoscopy intervals in familial colorectal cancer.

Authors:  Matthew F Kalady
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

2.  Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.

Authors:  Uri Ladabaum; Angel Ferrandez; Angel Lanas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-01       Impact factor: 4.254

3.  How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?

Authors:  Janneke A Wilschut; Ewout W Steyerberg; Monique E van Leerdam; Iris Lansdorp-Vogelaar; J Dik F Habbema; Marjolein van Ballegooijen
Journal:  Cancer       Date:  2011-03-08       Impact factor: 6.860

4.  Improving calculation, interpretation and communication of familial colorectal cancer risk: protocol for a randomized controlled trial.

Authors:  Nicky Dekker; Rosella P M G Hermens; Glyn Elwyn; Trudy van der Weijden; Fokko M Nagengast; Peter van Duijvendijk; Simone Salemink; Eddy Adang; J Han J M van Krieken; Marjolijn J L Ligtenberg; Nicoline Hoogerbrugge
Journal:  Implement Sci       Date:  2010-01-28       Impact factor: 7.327

5.  Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.

Authors:  H F A Vasen; G Möslein; A Alonso; S Aretz; I Bernstein; L Bertario; I Blanco; S Bulow; J Burn; G Capella; C Colas; C Engel; I Frayling; N Rahner; F J Hes; S Hodgson; J-P Mecklin; P Møller; T Myrhøj; F M Nagengast; Y Parc; M Ponz de Leon; L Renkonen-Sinisalo; J R Sampson; A Stormorken; S Tejpar; H J W Thomas; J Wijnen; J Lubinski; H Järvinen; E Claes; K Heinimann; J A Karagiannis; A Lindblom; I Dove-Edwin; H Müller
Journal:  Fam Cancer       Date:  2009-09-18       Impact factor: 2.375

6.  Literacy assessment of family health history tools for public health prevention.

Authors:  C Wang; R E Gallo; L Fleisher; S M Miller
Journal:  Public Health Genomics       Date:  2010-01-04       Impact factor: 2.000

Review 7.  Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Authors:  Jan T Lowery; Dennis J Ahnen; Paul C Schroy; Heather Hampel; Nancy Baxter; C Richard Boland; Randall W Burt; Lynn Butterly; Megan Doerr; Mary Doroshenk; W Gregory Feero; Nora Henrikson; Uri Ladabaum; David Lieberman; Elizabeth G McFarland; Susan K Peterson; Martha Raymond; N Jewel Samadder; Sapna Syngal; Thomas K Weber; Ann G Zauber; Robert Smith
Journal:  Cancer       Date:  2016-06-03       Impact factor: 6.860

8.  A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial.

Authors:  Maria W J van Vugt van Pinxteren; Mariëtte C A van Kouwen; Martijn G H van Oijen; Theo van Achterberg; Fokko M Nagengast
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

9.  Most patients with colorectal tumors at young age do not visit a cancer genetics clinic.

Authors:  Lucia I H Overbeek; Nicoline Hoogerbrugge; Joannes H J M van Krieken; Fokko M Nagengast; Theo J M Ruers; Marjolijn J L Ligtenberg; Rosella P M G Hermens
Journal:  Dis Colon Rectum       Date:  2008-08       Impact factor: 4.585

10.  Focusing on patient needs and preferences may improve genetic counseling for colorectal cancer.

Authors:  Simone Salemink; Nicky Dekker; Carolien M Kets; Erica van der Looij; Wendy A G van Zelst-Stams; Nicoline Hoogerbrugge
Journal:  J Genet Couns       Date:  2012-08-23       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.